ClinicalTrials.gov
public full text
Public Domain
Combination Targeted Radiotherapy in Neuroendocrine Tumors
The primary aim of this project is to determine, what fraction of individuals with neuroendocrine tumors would show substantially improved tumor dosimetry with combined agent therapy compared to "best" single agent therapy and determine the magnitude of the potential tumor radiation dose increase.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Assessment of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy#1030705
- High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor#448268
- Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients#866656
- Stereotactic Radiosurgery With Sunitinib for Brain Metastases#852441
- Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors#892575
Record · ID 918906
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive